2267-47-2

Basic information

• Product Name: 1-(2,4-DIFLUOROPHENYL)ETHANOL
• Synonyms: 1-(2,4-DIFLUOROPHENYL)ETHANOL
• CAS NO: 2267-47-2
• Molecular Formula: C₈H₈F₂O
• Molecular Weight: 158.15
• Mol File: 2267-47-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(2,4-DIFLUOROPHENYL)ETHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,4-DIFLUOROPHENYL)ETHANOL(2267-47-2)
• EPA Substance Registry System: 1-(2,4-DIFLUOROPHENYL)ETHANOL(2267-47-2)

Safety Data

• Hazardous Substances Data: 2267-47-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-(2,4-DIFLUOROPHENYL)ETHANOL is used as a key intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity make it a valuable building block in the development of new drugs and medications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(2,4-DIFLUOROPHENYL)ETHANOL is utilized as an intermediate in the production of different agrochemicals, contributing to the development of more effective and environmentally friendly products for agricultural use.
Used in Organic Synthesis:
1-(2,4-DIFLUOROPHENYL)ETHANOL is employed as a reagent in organic synthesis, facilitating a range of reactions such as esterification, oxidation, and reduction. Its versatility in these processes makes it an essential component in the creation of diverse organic compounds.

Upstream product

• 67-56-1 methanol 
• 364-83-0 2',4'-difluoroacetophenone 
• 555-31-7 aluminum isopropoxide 
• 372-18-9 1,3-Difluorobenzene 
• 1550-35-2 2,4-difluorobenzaldehyde 
• 75-16-1 methylmagnesium bromide 

Downstream Products

• 85068-30-0 2',4'-difluoropropiophenone 

Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Disclosed by the present invention are a nitrogen-containing heterocyclic compound, and a composition thereof, a preparation method therefor and an application thereof. The structure of the nitrogen-containing heterocyclic compound according to the presen

ATF6 MODULATORS AND USES THEREOF

Compounds (I) as modulators of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.

COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

Described herein are compounds that act as CYP46A1 inhibitors, compositions comprising these compounds, and methods of their use into treating neurodegenerative diseases and the like, or a pharmaceutically active salt thereof. The present invention relates to compounds represented by the formula wherein each symbol is as defined in the specification, or a pharmaceutically active salt thereof.

Dual cobalt-copper light-driven catalytic reduction of aldehydes and aromatic ketones in aqueous media

We present an efficient, general, fast, and robust light-driven methodology based on earth-abundant elements to reduce aryl ketones, and both aryl and aliphatic aldehydes (up to 1400 TON). The catalytic system consists of a robust and well-defined aminopyridyl cobalt complex active for photocatalytic water reduction and the [Cu(bathocuproine)(Xantphos)](PF6) photoredox catalyst. The dual cobalt-copper system uses visible light as the driving-force and H2O and an electron donor (Et3N or iPr2EtN) as the hydride source. The catalytic system operates in aqueous mixtures (80-60% water) with high selectivity towards the reduction of organic substrates (>2000) vs. water reduction, and tolerates O2. High selectivity towards the hydrogenation of aryl ketones is observed in the presence of terminal olefins, aliphatic ketones, and alkynes. Remarkably, the catalytic system also shows unique selectivity for the reduction of acetophenone in the presence of aliphatic aldehydes. The catalytic system provides a simple and convenient method to obtain α,β-deuterated alcohols. Both the observed reactivity and the DFT modelling support a common cobalt hydride intermediate. The DFT modelled energy profile for the [Co-H] nucleophilic attack to acetophenone and water rationalises the competence of [CoII-H] to reduce acetophenone in the presence of water. Mechanistic studies suggest alternative mechanisms depending on the redox potential of the substrate. These results show the potential of the water reduction catalyst [Co(OTf)(Py2Tstacn)](OTf) (1), (Py2Tstacn = 1,4-di(picolyl)-7-(p-toluenesulfonyl)-1,4,7-triazacyclononane, OTf = trifluoromethanesulfonate anion) to develop light-driven selective organic transformations and fine solar chemicals.

ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.

Substituted triazole diamine derivatives as kinase inhibitors

The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder.

2″-deoxy hygromycin derivatives

This invention relates to compounds of the formula and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1and R2are as defined herein. The compounds of formula 1 are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial and protozoal infections by administering the compounds of formula 1.